Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 3
1991 1
1992 1
1994 1
1997 1
2000 3
2001 1
2002 4
2004 3
2005 4
2006 8
2007 7
2008 4
2009 6
2010 8
2011 7
2012 7
2013 8
2014 6
2015 10
2016 5
2017 5
2018 7
2019 10
2020 6
2021 7
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

109 results
Results by year
Filters applied: . Clear all
Page 1
Actively personalized vaccination trial for newly diagnosed glioblastoma.
Hilf N, Kuttruff-Coqui S, Frenzel K, Bukur V, Stevanović S, Gouttefangeas C, Platten M, Tabatabai G, Dutoit V, van der Burg SH, Thor Straten P, Martínez-Ricarte F, Ponsati B, Okada H, Lassen U, Admon A, Ottensmeier CH, Ulges A, Kreiter S, von Deimling A, Skardelly M, Migliorini D, Kroep JR, Idorn M, Rodon J, Piró J, Poulsen HS, Shraibman B, McCann K, Mendrzyk R, Löwer M, Stieglbauer M, Britten CM, Capper D, Welters MJP, Sahuquillo J, Kiesel K, Derhovanessian E, Rusch E, Bunse L, Song C, Heesch S, Wagner C, Kemmer-Brück A, Ludwig J, Castle JC, Schoor O, Tadmor AD, Green E, Fritsche J, Meyer M, Pawlowski N, Dorner S, Hoffgaard F, Rössler B, Maurer D, Weinschenk T, Reinhardt C, Huber C, Rammensee HG, Singh-Jasuja H, Sahin U, Dietrich PY, Wick W. Hilf N, et al. Among authors: gouttefangeas c. Nature. 2019 Jan;565(7738):240-245. doi: 10.1038/s41586-018-0810-y. Epub 2018 Dec 19. Nature. 2019. PMID: 30568303 Clinical Trial.
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.
Nelde A, Bilich T, Heitmann JS, Maringer Y, Salih HR, Roerden M, Lübke M, Bauer J, Rieth J, Wacker M, Peter A, Hörber S, Traenkle B, Kaiser PD, Rothbauer U, Becker M, Junker D, Krause G, Strengert M, Schneiderhan-Marra N, Templin MF, Joos TO, Kowalewski DJ, Stos-Zweifel V, Fehr M, Rabsteyn A, Mirakaj V, Karbach J, Jäger E, Graf M, Gruber LC, Rachfalski D, Preuß B, Hagelstein I, Märklin M, Bakchoul T, Gouttefangeas C, Kohlbacher O, Klein R, Stevanović S, Rammensee HG, Walz JS. Nelde A, et al. Among authors: gouttefangeas c. Nat Immunol. 2021 Jan;22(1):74-85. doi: 10.1038/s41590-020-00808-x. Epub 2020 Sep 30. Nat Immunol. 2021. PMID: 32999467
[Tumor vaccines-therapeutic vaccination against cancer].
Rammensee HG, Löffler MW, Walz JS, Bokemeyer C, Haen SP, Gouttefangeas C. Rammensee HG, et al. Among authors: gouttefangeas c. Internist (Berl). 2020 Jul;61(7):690-698. doi: 10.1007/s00108-020-00814-z. Internist (Berl). 2020. PMID: 32462251 Review. German.
Personalized cancer vaccines: adjuvants are important, too.
Gouttefangeas C, Rammensee HG. Gouttefangeas C, et al. Cancer Immunol Immunother. 2018 Dec;67(12):1911-1918. doi: 10.1007/s00262-018-2158-4. Epub 2018 Apr 11. Cancer Immunol Immunother. 2018. PMID: 29644387 Review.
Immunorejuvenation in the elderly.
Pawelec G, Koch S, Gouttefangeas C, Wikby A. Pawelec G, et al. Among authors: gouttefangeas c. Rejuvenation Res. 2006 Spring;9(1):111-6. doi: 10.1089/rej.2006.9.111. Rejuvenation Res. 2006. PMID: 16608407 Review.
A framework for T cell assays.
Britten CM, van der Burg SH, Gouttefangeas C. Britten CM, et al. Among authors: gouttefangeas c. Oncotarget. 2015 Nov 3;6(34):35143-4. doi: 10.18632/oncotarget.6181. Oncotarget. 2015. PMID: 26506424 Free PMC article. No abstract available.
CD4+ T Cells: Multitasking Cells in the Duty of Cancer Immunotherapy.
Richardson JR, Schöllhorn A, Gouttefangeas C, Schuhmacher J. Richardson JR, et al. Among authors: gouttefangeas c. Cancers (Basel). 2021 Feb 3;13(4):596. doi: 10.3390/cancers13040596. Cancers (Basel). 2021. PMID: 33546283 Free PMC article. Review.
Immunotherapy of renal cell carcinoma.
Gouttefangeas C, Stenzl A, Stevanović S, Rammensee HG. Gouttefangeas C, et al. Cancer Immunol Immunother. 2007 Jan;56(1):117-28. doi: 10.1007/s00262-006-0172-4. Epub 2006 May 5. Cancer Immunol Immunother. 2007. PMID: 16676181 Review.
Immunosenescence, suppression and tumour progression.
Pawelec G, Koch S, Griesemann H, Rehbein A, Hähnel K, Gouttefangeas C. Pawelec G, et al. Among authors: gouttefangeas c. Cancer Immunol Immunother. 2006 Aug;55(8):981-6. doi: 10.1007/s00262-005-0109-3. Epub 2005 Dec 6. Cancer Immunol Immunother. 2006. PMID: 16333622 Review.
109 results